The basic science and clinical studies carried out by hematology faculty cover a broad range of hematologic malignancies and blood disorders. Clinical investigators in the Division utilize discoveries from laboratories worldwide to develop and test novel therapeutic approaches to improve patient outcomes.
IPS cells slow tumor growth in mice
Priming the immune system with induced pluripotent stem cells prevented or slowed the development of cancer in mice, Stanford researchers found.
Faculty get funding from stem cell agency
Three Stanford faculty members were awarded $6 million to support research into a blistering skin disease, transplanted stem cells and novel ways to grow blood stem cells.
Stem cells for fat have circadian clock
New discoveries about the circadian-clock machinery in the precursors to fat cells may explain why shift workers are prone to metabolic diseases, such as diabetes, a Stanford study finds.
RNA labeling reveals stem cell secrets
The Stanford research suggests that any conclusions about stem cell function based on studies of stem cells in lab dishes may now need to be reconsidered in light of the fact that the cells’ biology changes during isolation.
Researchers discover lung stem cell in mice
Stanford scientists have found a cell that creates the two different compartments in the mouse lung. They hope their discovery could lead to better therapies for people with lung disease.
Conferences and Workshops
Stanford Cancer Immunotherapy and Blood and Marrow Transplant Symposium: Update on Current Advances in BMT and Cancer Immunotherapy
Frances C. Arrillaga Alumni Center, McCaw Hall, Stanford CA
New courses are added regularly— please check back often
Join the Mailing List
New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.